The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

Rationale & Objective Coronavirus disease 2019 (COVID-19) may be associated with high
rates of acute kidney injury (AKI) and kidney replacement therapy (KRT), potentially …

Background Patients with hematological malignancies (HM) are at high risk of mortality from
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …

Importance Acute kidney injury (AKI) occurs in up to half of patients hospitalized with
coronavirus disease 2019 (COVID-19). The longitudinal effects of COVID-19–associated AKI …

Coronavirus disease 2019 (COVID-19), primarily affecting respiratory systems, has become
pandemic and spread worldwide. Acute kidney injury (AKI) has been reported as a severe …

ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the
COVID-19 pandemic, it has become one of the most therapeutically targeted human …

Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus
Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80 …

Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …

The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period.
The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major …

Background There are limited data on acute kidney injury (AKI) progression and long-term
outcomes in critically ill patients with coronavirus disease-19 (COVID-19). We aimed to …